Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 4, 2014, Pages 1050-1056

  Livermore, David M ^a,b   Mushtaq, Shazad ^a   Warner, Marina ^a   Woodford, Neil ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Cystic fibrosis; Non fermenters; Stenotrophomonas maltophilia

Indexed keywords

CARBAPENEMASE; CEFOTAXIME; CLAVULANIC ACID; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOLIC ACID ANTAGONIST; IMIPENEM; LIDAPRIM; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; RNA 16S; SULFONAMIDE; TIGECYCLINE;

ACINETOBACTER BAUMANNII; AGAR DILUTION; ALCALIGENES; ARTICLE; BACTERIAL STRAIN; BURKHOLDERIA; CHRYSEOBACTERIUM; COMPARATIVE STUDY; DRUG SENSITIVITY; ELIZABETHKINGIA; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; GENE SEQUENCE; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STENOTROPHOMONAS MALTOPHILIA;

CYSTIC FIBROSIS; NON-FERMENTERS; STENOTROPHOMONAS MALTOPHILIA;

ANTI-BACTERIAL AGENTS; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; SULFAMETHOXAZOLE; SULFANILAMIDES; TRIMETHOPRIM;

EID: 84896442957     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt455     Document Type: Article

References (21)

1. Enne VI, Livermore DM, Stephens P et al. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 2001; 357: 1325-8.
2. GalesAC, Jones RN, Andrade SS et al. Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002). Mem Inst Oswaldo Cruz 2005; 100: 571-7.
3. Avgeri SG, Matthaiou DK, Dimopoulos G et al. Therapeutic options for Burkholderia cepacia infections beyond sulfamethoxazole-trimethoprim: a systematic review of the clinical evidence. Int J Antimicrob Agents 2009; 33: 394-404.
4. Abbott IJ, Slavin MA, Turnidge JD et al. Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment. Expert Rev Anti Infect Ther 2011; 9: 471-88.
5. Pogue JM, Marchaim D, Kaye D et al. Revisiting "older" antimicrobials in the era of multidrug resistance. Pharmacotherapy 2011; 31: 912-21.
6. Skold O. Resistance to trimethoprimand sulfonamides. Vet Res 2001; 32: 261-73.
7. Smith JT, Amyes SG. Bacterial resistance to antifolate chemotherapeutic agents mediated by plasmids. Br Med Bull 1984; 40: 42-6.
8. Vouloumanou EK, Karageorgopoulos DE, Rafailidis PI et al. Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence. Int J Antimicrob Agents 2011; 38: 197-216.
9. Abdel-Messih EF, Suleiman MN, Baron JM. In-vitro comparative study of Lidaprim and co-trimoxazole. J Int Med Res 1984; 12: 219-20.
10. Nabert-Bock G, Grims H. Bacteriological studyon the chemotherapeutic combination sulfametrole-trimethoprim/comparison with co-trimoxazole. Arzneimittelforschung 1977; 27: 1109-17.
11. OXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol 2006; 44: 2974-6.
12. McNulty CA, Richards J, Livermore DM et al. Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother 2006; 58: 1000-8.
13. Clinical Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically: Approved Standard M7-A9. CLSI,Wayne PA, USA, 2009.
14. Di Nocera PP, Rocco F, Giannouli M et al. Genome organization of epidemic Acinetobacter baumannii strains. BMC Microbiol 2011; 11: 224.
15. Nigro SJ, Post V, Hall RM. The multiresistant Acinetobacter baumannii European clone I type strain RUH875 (A297) carries a genomic antibiotic resistance island AbaR21, plasmid pRAY and a cluster containing ISAba1-sul2-CR2-strB-strA. J Antimicrob Chemother 2011; 66: 1928-30.
16. Toleman MA, Bennett PM, Bennett DM et al. Global emergence of trimethoprim/sulfamethoxazole resistance in Stenotrophomonas maltophilia mediated by acquisition of sul genes. Emerg Infect Dis 2007; 13: 559-65.
17. KPC-5-harboring IncN and IncX plasmids from Klebsiella pneumoniae strains isolated in New Jersey. Antimicrob Agents Chemother 2013; 57: 269-76.
18. Ho PL, Lo WU, Yeung MK et al. Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong. PLoS One 2011; 6: e17989.
19. Miriagou V, Papagiannitsis CC, Kotsakis SD et al. Sequence of pNL194, a 79.3-kilobase IncN plasmid carrying the blaVIM-1 metallo-β-lactamase gene in Klebsiella pneumoniae. Antimicrob Agents Chemother 2010; 54: 4497-502.
20. Woodford N, Carattoli A, Karisik E et al. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob Agents Chemother 2009; 53: 4472-82.
21. Oteo J, Hernandez-Almaraz JL, Gil-Anton J et al. Outbreak of VIM-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit. Pediatr Infect Dis J 2010; 29: 1144-6.